Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Muscle-Pacing Technology Found to Increase Targeted Bone Volume by 30%

By BiotechDaily International staff writers
Posted on 02 Jul 2014
Print article
Image: The muscle pacing method used in the study saw the rats gain 30% of bone within the targeted areas (Photo courtesy of the University of Liverpool).
Image: The muscle pacing method used in the study saw the rats gain 30% of bone within the targeted areas (Photo courtesy of the University of Liverpool).
In an important advance for the health of older individuals, researchers have developed a new way to target bone growth. As people age, their bones lose density, and particularly in women after the menopause, become more brittle. The new technique offers the possibility of more effective treatment than currently available. The muscle-pacing technology revealed that the lab rats in the study gained 30% of bone within the targeted areas.

The new technology was developed by researchers from the University of Liverpool’s (UK) Institute of Aging and Chronic Disease. Prof. Jonathan Jarvis, from Liverpool John Moores University designed miniature muscle pacemakers that were used in the University of Liverpool labs to generate contractions in the muscles of the legs of rats over 28 days. University of Liverpool PhD student Paula Vickerton led the research. She said, “Bone disease and fragility are affecting an increasing proportion of our population. However, existing treatments are nonspecific, affecting whole bones and not just the weaker regions.”

Using the muscle-pacing technique, the rats gained 30% of bone within the targeted areas. Ms. Vickerton’s supervisor, Dr. Nathan Jeffery, said, “This method has been shown to increase the amount of bone and raises the possibility of being developed into a treatment for people who are at risk of the many complications that weakened bone can bring.”

The study’s findings were published online and slated for the August 7, 2014 issue of the journal Proceedings of the Royal Society B: Biological Sciences.

Related Links:

University of Liverpool



Print article

Channels

Drug Discovery

view channel
Image: A scanning electron microscope (SEM) image of methicillin-resistant Staphylococcus aureus bacteria (Photo courtesy of the CDC).

Drug Combination Cures MRSA Infection While Preventing Development of Resistance

Treatment with a combination comprising the well-known antibiotic cefdinir and the experimental drug TXA709 cured mice of drug-resistant staphylococcal infections while reducing the development of resistance.... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Business

view channel

Acquisition to Boost Development of Drugs for Neurogenic Conditions

According to a recent announcement, a privately held biotechnology/drug development company is to be acquired by one of the major pharmaceutical manufacturers. The drug manufacturer Merck & Co. (Kenilworth, NJ, USA) has agreed to pay 500 million USD up front for Afferent Pharmaceuticals (San Mateo, CA, USA) and up... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.